Atlas Trials

Serum Hepatitis B Surface Antigen Levels to Guide the Stopping of Entecavir in HBeAg-negative Chronic Hepatitis B

Clinical trial NCT02069678 · COMPLETED

Trial details

NCT number
NCT02069678
Sponsor
Chinese University of Hong Kong
Status
COMPLETED
Study type
OBSERVATIONAL
Chronic Hepatitis B
Start date
2012-03-01
Primary completion
2013-09-01
Enrollment
82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.